Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurology and Therapy
Published in: Neurology and Therapy 1/2018

Open Access 01-06-2018 | Editorial

Editorial Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives

Author: Thomas Müller

Published in: Neurology and Therapy | Issue 1/2018

Login to get access

Excerpt

Alzheimer’s disease, Lewy body dementia, Parkinson’s disease dementia, vascular dementia, and vascular Parkinsonism are frequently occuring syndromes of chronic brain neurodegeneration. They cause an enormous burden for healthcare. All these terms reflect disease entities; in other words, they are not specific, and their features and progression overlap. Thus, their drug treatment needs an individually adapted not a standardised regimen. …
Literature
1.
Larner AJ. Correlation or limits of agreement? applying the Bland–Altman approach to the comparison of cognitive screening instruments. Dement Geriatr Cogn Disord. 2016;42(5–6):247–54.CrossRefPubMed
2.
Seigerschmidt E, Mosch E, Siemen M, Forstl H, Bickel H. The clock drawing test and questionable dementia: reliability and validity. Int J Geriatr Psychiatry. 2002;17(11):1048–54.CrossRefPubMed
3.
Sian-Hulsmann J, Monoranu C, Strobel S, Riederer P. Lewy bodies: a spectator or salient killer? CNS Neurol Disord Drug Targets. 2015;14(7):947–55.CrossRefPubMed
4.
Kumar P, Jha NK, Jha SK, Ramani K, Ambasta RK. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer’s disease. J Alzheimers Dis. 2015;43(2):341–61.CrossRefPubMed
5.
6.
7.
Metadata
Title
Editorial Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives
Author
Thomas Müller
Publication date
01-06-2018
Publisher
Springer Healthcare
Published in
Neurology and Therapy / Issue 1/2018
Print ISSN: 2193-8253
Electronic ISSN: 2193-6536
DOI
https://doi.org/10.1007/s40120-018-0100-5

Other articles of this Issue 1/2018

Neurology and Therapy 1/2018 Go to the issue

Review

5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress

Original Research

Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

Commentary

Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine

Case Series

Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series

Letter

Author’s Response to the Letter to the Editor Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives

Commentary

Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives